UID:
edocfu_9958078507002883
Format:
xviii, 433 pages :
,
illustrations ;
,
23 cm.
Edition:
1st ed.
ISBN:
1-280-08548-7
,
9786610085484
,
0-585-49593-9
Series Statement:
Health, nutrition, and population series
Note:
Bibliographic Level Mode of Issuance: Monograph
,
Intro -- Contents -- Foreword -- Acknowledgments -- Introduction -- 1 What Is the Minimum a Doctor Should Know about Health Economics? -- 2 Public and Private Roles in Health -- 3 The Rationale for Government Intervention in the Tobacco Market -- 4 Measurement of Equity in Health -- 5 What Should Consumers in Poor Countries Pay for Publicly-Provided Health Services? -- 6 Compensatory Finance in Health:Geographic Equity in a Federal System -- 7 An Ounce of Prevention Is Worth How Much Cure? -- 8 DALYs and Cost-Effectiveness Analysis -- 9 Criteria for Public Spending on Health Care -- 10 Cost-Effectiveness and the Socialization of Health Care -- 11 Is the Eradication of Polio in the Western Hemisphere Economically Justified? -- 12 Cost-Benefit Analysis of a Regional Vaccination System -- 13 Cost-Effective Malaria Control in Brazil -- 14 Do the Poor in Brazil Pay More for Food? -- 15 Do Brazilian Nutrition Programs Make a Difference? -- 16 Economic Aspects of Food Fortification -- 17 Malnutrition and Dietary Protein -- 18 Family Health Care Spending in Latin America -- 19 Basic Patterns in National Health Expenditure -- 20 Economic Crisis and Health Policy Response -- Index -- Tables -- I.1 Principal Differences between Health Insurance and Insurance for Nonhuman Assets -- I.2 Principal Differences and Similarities between Education and Health -- 4.1 Measures Related to Equity in Health Care, Peru, 1982: Health Care Resources and Sanitation Services -- 4.2 Measures Related to Equity in Health Care in Peru, 1984: Morbidity and Medical Attention -- 4.3 Measures Related to Equity in Health Care in Peru, 1984: Consultations, Hospitalizations and Expenditures -- 4.4 Measures Related to Equity In Health Care in Peru, 1984: Vaccination Coverage (%) of Children Under 5.
,
11.1 Costs and Benefits Associated with Polio Eradication During a Successful Five-Year Campaign and an Ensuing Ten-Year Maintenance Period,Assuming all Polio Victims are Treated -- 11.2 Costs and Benefits Associated with Polio Eradication During a Successful Five-Year Campaign and Ten-Year Maintenance Period,Assuming only a Fraction of all Polio Victims are Treated -- 11.3 A Comparison of Ten-Year Costs and Results of Two Hypothetical Polio Eradication Campaigns, One Immediate and One Delaye -- 12.1 Cost of SIREVA, by Year, in Constant US -- 12.2 The Projected Numbers of Individuals to be Vaccinated, by Target Disease and Year -- 12.3 Total Discounted Numbers of Disease Cases Prevented, Deaths Prevented with Treatment of all Cases, and Deaths Prevented -- 12.4 The Estimated Cost of Treatment (in Constant US), Probability of Preventing One Case, and Implied Maximum Cost of Vacci -- 12.5 The Average Implied Maximum Cost of Vaccination (in Constant US) Derived from the Number of Individuals Vaccinated, Tre -- 12.6 Implied Minimum Benefit per Case Prevented and per Death Prevented as a Function of the Cost of Vaccination, without Con -- 12.7 The Effects of Adjusting for the Delay between Vaccination and Disease Onset upon the Implied Maximum Cost of Vaccination and upon the Implied Minimum Benefits of Preventing a Disease Case,in Constant US -- 13.1 Population (Millions) and Number of Municipalities by Risk of Malaria Transmission, Based on API, 1988-1995 -- 13.2 Estimated Cases, Lives and DALYs Saved by Preventing and Treating Malaria, 1989-1996. Cases Prevented and Cases Reported -- 13.3 Estimated Cases, Lives and DALYs Saved by Preventing and Treating Malaria, 1989-1996. Conversion of Savings in Lives and -- 13.4 Costs of the Malaria Control Program, 1989-1996 (Thousands of 1996 US, Discounted at 3% for 1989-1995) and Cases Treate.
,
13.5 Cost-Effectiveness of Saving Lives from Falciparum, 1989-1992, 1993-1996 (Discounted Present Values). Most Plausible As -- 13.6 Cost-Effectiveness of Saving Lives from Falciparum, 1989-1992, 1993-1996 and 1989-1996 (Discounted Present Values). Sen -- 13.7 Cost-Effectiveness of Saving Lives from Falciparum, 1989-1996 (Discounted Present Values). Sensitivity Analysis: Untreat -- 13.8 Effects of Reduced Incidence, Severity and Lethality on Mortality Reduction -- 14.1 Sample Size (Number of Retailers) by City Size, Type of Neighborhood, and Type of Establishment -- 14.2 Mean Prices, in June 1985 Cruzeiros, of Selected Basic Foods by Municipality for Small Retailers Not Affiliated with Sub -- 14.3 Mean Prices, in June 1985 Cruzeiros, of Selected Basic Foods by City Size for Small Retailers Not Affiliated with Subsid -- 14.4 Mean Prices, in June 1985 Cruzeiros, of Selected Basic Foods by Type of Establishment: Three Metropolitan Areas -- 14.5 Mean Prices, in June 1985 Cruzeiros, of Selected Basic Foods by Type of Establishment: Six Medium-Size Cities -- 14.6 Prices as Functions of City, Neighborhood, and Type of Establishment:Regression Coefficients -- 14.7 Quadratic Regression of Price versus Quantity for Fractional Purchases of Eight Basic Foods, in all Establishments and S -- 15.1 Principal Characteristics of Four Nutrition Programs, Brazil, 1974-86 -- 15.2 Aggregate Estimates for Physical Distribution of Foods, Total Cost, and Total Public Expenditure at Constant June 1984 P -- 15.3 PINS: Number of Families Entitled to Purchase Subsidized Food ("Participating ") and Number of Families that Actually Bo -- 15.4 Changes Observed in Weight for Age in Children Participating in the PNS in Two Municipalities in São Paulo, March 1980-A -- 15.5 PNS, PCA, and PINS: Cost Structure in Percentage Terms (Data for One or More Years between 1978 and 1980).
,
15.6 Recife, Pernambuco: Subsidy Level (Percentage) and PROAB Prices (Percentage Difference from Supermarket Price, with and -- 15.7 Actual Transfer of the PROAB Subsidy to the Consumer, in Relation to Minimarket Prices, Recife, March-August 1984 -- 15.8 Changes Observed in Children Participating in the PCA, PNS, or PINS, According to Anthropometric Criterion, Duration of -- 15.9 Changes in Weight for Age in Initially Underweight Children Participating in the PNS or PINS, by Program, Initial Age, a -- 15.10 Number of Children Initially Aged Under Six Participating in the PINS, According to Initial and Final Nutritional Statu -- 15.11 Changes in Weight for Age Observed in Children Initially Aged Under 12 Months, Participating in the PINS, According to -- 15.12 Changes Observed in Children Participating in the PNS, Initially Aged between 6 and 12 Months Old, According to Anthrop -- 15.13 Weights of Live Births to Mothers who were Beneficiaries of the PNS and PCA, Compared with Non-Beneficiaries -- 17.1 Variables for Urban China in 1979 -- 17.2 Determinants of the Height and Weight of Young Adults (Age 18 -25 Years) in Urban China in 1979 -- 17.3 Variables for Rural Chinese Counties in 1983 -- 17.4 Determinants of Adult Height and Weight in Rural Chinese Counties in 1983 -- 17.5 Variables for International Comparisons -- 17.6 Determinants of Adult Male Height (41 Populations in 40 Countries) and Adult Female Height (33 Populations in 32 Countri -- 18.1 Elasticities with Respect to Total Expenditure -- 18.2 Estimated Total Family Expenditure per Person and Private Health Care Expenditure, by Quartile 1 (low) to 4 (high) of To -- 18.3 Mean Values of Total Family Expenditure (PCE) and Private Health Care Spending (HEA), within Each of Nine Classes of Tot.
,
18.4 Brazil, 1974: Private Family Health Care Spending as a Function of Total Family Expenditure, Region and Metropolitan/Oth -- 18.5 Mean Values of Private Family Expenditure on Drugs and Medicines and on Hospitalization and Surgery, within Each of Nine -- 19.1 National Health Accounts Estimates for 191 WHO Member States for 1997, Revised Data as of 31 May 2001 -- 19.2 Countries Grouped by WHO Region, Mortality Stratum, and GDP per Capita -- 19.3 Regression Statistics for Health Expenditure as a Percentage of Gross Domestic Product -- 19.4 Regression Statistics for Out of Pocket Payments as a Percentage of Total Health Expenditure -- 19.5 Regression Statistics for Public Health Expenditure as a Percentage of Total Health Expenditure -- 19.6 Regression Statistics for Public Health Expenditure as a Percentage of Total Public Expenditure -- 19.7 Regression Statistics for Out-of-Pocket Payments per Capita as a Function of Income per Capita -- 19.8 Regression Statistics for Total Health Expenditure per Capita as a Function of Income per Capita -- 19.9 Regression Statistics for Total Public Expenditure per Capita as a Function of Income per Capita -- 20.1 Indices of Public Expenditures on Health (Central Government or Total Public Sector) in Thirteen Latin American and Cari -- Figures -- I.1 Decision Flowchart, Sources of Health Financing -- 2.1 Three Domains of Health Care -- 2.2 Need, Demand and Supply for Health Care -- 2.3A Appropriate Use of the Instruments of Public Intervention in Health Care -- 2.3B Typically Inappropriate Use of the Instruments of Public Intervention in Health Care -- 4.1 Schematic Stages of Illness or Accident, Treatment and Outcome -- 4.2 Lorenz Curves of Inequality of the Distribution of Physicians Rrelative to Population (by Department) and of Ministry of -- 5.1 Demand for Medical Care as a Function of Income and Prices.
,
7.1 Marginal Costs of a Curative and a Preventive Intervention, when Prevention is Always Cheaper and Everyone Receives One I.
,
English
Additional Edition:
ISBN 0-8213-5570-8
Language:
English
Bookmarklink
